Financial report interval: 2025.07.01 - 2025.12.31
Preview: LUYE PHARMA(02186) predict that the Revenue is 3.478 B (+9.44%), Miss estimate;the EBIT is 645.03 M (+38.66%), Miss estimate;the EPS is 0.0465 (+95.93%), Miss estimate.